-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:12 GMT
… non-small cell lung cancer following surgery and … Platform (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … combination with platinum (cisplatin or carboplatin) and …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:06 GMT
… non-small cell lung cancer following surgery and … Platform (ETOP).
About lung cancer
Lung cancer is the leading … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … combination with platinum (cisplatin or carboplatin) and …
-
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report
24 Jan 2023 11:55 GMT
… Keywords: non-small cell lung cancer, ALK, alectinib, drug … with 2 cycles of cisplatin plus pemetrexed) without … and extravascular hemolysis in lung cancer patients receiving alectinib. Cancers … positive non-small-cell lung cancer. Lung Cancer. 2020;139:195–199 …
-
FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer
23 Jan 2023 17:32 GMT
… to IIIA non-small cell lung cancer (NSCLC) whose tumors have PD … had complete tumor resection and cisplatin-based adjuvant chemotherapy were randomized …
-
Real-World Treatment and Outcomes of ALK-Positive Metastatic Non–Small Cell Lung Cancer in a Southeast Asian Country
13 Jan 2023 03:58 GMT
… a diagnosis of primary lung cancer (confirmed cytologically or … received first-line chemotherapy (cisplatin and pemetrexed) (Table 3 … positive non-small cell lung cancer. Lung Cancer. 2018;116:15–24 … Cell Lung Cancer in the United States. Clin Lung Cancer. 2022 …
-
Overweight and Obesity are Associated with Poorer Survival Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Platinum-Based Chemotherapy
06 Jan 2023 12:27 GMT
… patients with advanced lung cancer, particularly those … lung cancer: frequency, diagnostic characteristics, and survival. Transl Lung Cancer … of resected lung cancer independently of tumor … cisplatin in Japanese patients with advanced non-small-cell lung cancer …
-
AstraZeneca: Imfinzi + Imjudo Approved In Japan For Advanced Liver, Biliary Tract And Lung Cancers
28 Dec 2022 07:44 GMT
… advanced liver, biliary tract and lung cancers.
Imfinzi plus Imjudo has been … or recurrent non-small cell lung cancer or NSCLC in combination with … combination with chemotherapy (gemcitabine plus cisplatin).
Dave Fredrickson, Executive Vice President …
-
Extensive Stage Small Cell Lung Cancer Global Market Report 2022: Approval of Immune Checkpoint Inhibitors as Combination Therapy Broadens the Horizon - ResearchAndMarkets.com
19 Dec 2022 14:19 GMT
… etoposide in combination with platinum (cisplatin or carboplatin) were the treatment … Small Cell Lung Cancer
The prevalence of extensive stage small lung cancer is estimated … for extensive stage small cell lung cancer. Moreover, a detailed competitive …
-
Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases
13 Dec 2022 23:43 GMT
… lung cancer is classified as small cell lung cancer (SCLC) or non–small cell lung cancer … from small cell lung cancer: consequences of … cisplatin in the treatment of extensive-disease small-cell lung cancer … in small-cell lung cancer. Clin Lung Cancer. 2008;9 …
-
Stage 4 neuroendocrine small cell lung cancer
07 Dec 2022 10:43 GMT
… lung cancers. It is also the most prevalent type of neuroendocrine lung tumor.
Neuroendocrine lung tumors … results suggest the possibility of lung cancer, doctors may ask a person … the chemotherapy drugs etoposide and cisplatin or carboplatin.
A 2020 review …
About
© 1995-2023